HopeStage
Study directory

Addiction studies

Addiction involves difficulty controlling substance use or a behaviour despite its harmful effects on everyday life.

Back to overview
More filters: keywords, city, remote
713studies shown
Showing 613-624 of 713
Biological study icon
RecruitingNCT05490732

Pharmacokinetic Modeling of Methadone

Official study title

Pharmacokinetic Population Modeling of Methadone in Patients Managed for Opioid Opioid Addiction

In Montpellier
AddictionInterventional studyAges 18–99
Countries
France
Sponsor
University Hospital, Montpellier
Behavioral study icon
RecruitingNCT07052175

Prevention of Relapse in Behavioral Disorders

Official study title

Prevention of Relapse in Behavioral Disorders: Study Protocol of a Randomized Control Trial

Multiple locations, including Ciempozuelos
AddictionBehavioural studyAges 18–90
Countries
Spain
Sponsor
Clínica Nuestra Señora de la Paz
Drug study icon
RecruitingNCT06899594

Psilocybin for Methamphetamine Addiction

Official study title

A Pilot Study in North Louisiana to Assess the Tolerability of Psilocybin as Well as Its Capacity to Promote Abstinence From Methamphetamine

In Shreveport
AddictionMedication studyAges 25–65
Countries
United States
Sponsor
Kevin Murnane
Other study type icon
RecruitingACTRN12619000159156

Controlled study of electronic resources to help smokers quit

Official study title

Randomised controlled trial into the acceptability and effect of My Quit Buddy smartphone app on the self-reported quit rate in smokers

In Australia
AddictionInterventional studyAges 18+
Countries
Australia
Sponsor
The Prince Charles Hospital
Device study icon
RecruitingNCT04903028

RTMS Targets Neural Circuits for Smoking Cessation

Official study title

RTMS Manipulates Imbalanced Drive-reward and Executive Control Circuitry for Smoking Cessation

In Charleston
AddictionDevice studyAges 22–70
Countries
United States
Sponsor
Medical University of South Carolina
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.